Raftery Rosanne M, Woods Brian, Marques Ana L P, Moreira-Silva Joana, Silva Tiago H, Cryan Sally-Ann, Reis Rui L, O'Brien Fergal J
Tissue Engineering Research Group, Dept. of Anatomy, Royal College of Surgeons in Ireland, 123, St. Stephens Green, Dublin 2, Dublin, Ireland; Trinity Centre for Bioengineering, Trinity College Dublin, Dublin 2, Dublin, Ireland; Advanced Materials and Bioengineering Research Centre (AMBER), RCSI and TCD, Dublin, Ireland.
3B's Research Group - Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's - PT Government Associate Laboratory, Braga/Guimarães, Portugal.
Acta Biomater. 2016 Oct 1;43:160-169. doi: 10.1016/j.actbio.2016.07.009. Epub 2016 Jul 8.
Natural biomaterials such as collagen show promise in tissue engineering applications due to their inherent bioactivity. The main limitation of collagen is its low mechanical strength and somewhat unpredictable and rapid degradation rate; however, combining collagen with another material, such as chitosan, can reinforce the scaffold mechanically and may improve the rate of degradation. Additionally, the high cost and the risk of prion transmission associated with mammal-derived collagen has prompted research into alternative sources such as marine-origin collagen. In this context, the overall goal of this study was to determine if the incorporation of chitosan into collagen scaffolds could improve the mechanical and biological properties of the scaffold. In addition the study assessed if collagen, derived from salmon skin (marine), can provide an alternative to collagen derived from bovine tendon (mammal) for tissue engineering applications. Scaffold architecture and mechanical properties were assessed as well as their ability to support mesenchymal stem cell growth and differentiation. Overall, the addition of chitosan to bovine and salmon skin-derived collagen scaffolds improved the mechanical properties, increasing the compressive strength, swelling ratio and prolonged the degradation rate. Mesenchymal stem cell (MSC) attachment and proliferation was most improved on the bovine-derived collagen scaffold containing a 75:25 ratio of collagen:chitosan, and when MSC osteogenic and chondrogenic potential on the scaffold was assessed, a significant increase in calcium production (p<0.001) and sulfated glycosaminoglycan (sGAG) production (p<0.001) was observed respectively. Regardless of chitosan content, the bovine-derived collagen scaffolds out-performed the salmon skin-derived collagen scaffolds, displaying a larger pore size and higher percentage porosity, more regular architecture, higher compressive modulus, a greater capacity for water uptake and allowed for more MSC proliferation and differentiation. This versatile scaffold incorporating the marine biomaterial chitosan show great potential as appropriate platforms for promoting orthopaedic tissue repair while the use of salmon skin-derived collagen may be more suitable in the repair of soft tissues such as skin.
Collagen is commonly used in tissue engineering due to its biocompatibility; however, it has low mechanical strength and an unpredictable degradation rate. In addition, high cost and risk of prion transmission associated with mammalian-derived collagen has prompted research into alternative collagen sources, namely, marine-derived collagen. In this study, scaffolds made from salmon-skin collagen were compared to the more commonly used bovine-derived collagen with a focus on orthopaedic applications. To improve the mechanical properties of these scaffolds, another marine biomaterial, chitosan, was added to produce scaffolds with increased mechanical stability. The collagen-chitosan composites were also shown to support mesenchymal stem cell differentiation towards both bone and cartilage tissue. This multi-functional scaffold therefore has potential in both bone and cartilage regeneration applications.
天然生物材料如胶原蛋白因其固有的生物活性在组织工程应用中显示出前景。胶原蛋白的主要局限性在于其低机械强度以及 somewhat unpredictable and rapid degradation rate;然而,将胶原蛋白与另一种材料如壳聚糖结合,可以在机械上增强支架,并可能改善降解速率。此外,与哺乳动物来源的胶原蛋白相关的高成本和朊病毒传播风险促使人们研究替代来源,如海洋来源的胶原蛋白。在此背景下,本研究的总体目标是确定壳聚糖掺入胶原蛋白支架是否能改善支架的机械和生物学性能。此外,该研究评估了源自鲑鱼皮(海洋)的胶原蛋白是否可以替代源自牛肌腱(哺乳动物)的胶原蛋白用于组织工程应用。评估了支架结构和机械性能以及它们支持间充质干细胞生长和分化的能力。总体而言,向牛和鲑鱼皮来源的胶原蛋白支架中添加壳聚糖改善了机械性能,提高了抗压强度、溶胀率并延长了降解速率。在含有 75:25 胶原蛋白:壳聚糖比例的牛来源胶原蛋白支架上,间充质干细胞(MSC)的附着和增殖得到最大改善,并且当评估支架上 MSC 的成骨和成软骨潜力时,分别观察到钙产量(p<0.001)和硫酸化糖胺聚糖(sGAG)产量(p<0.001)显著增加。无论壳聚糖含量如何,牛来源的胶原蛋白支架都优于鲑鱼皮来源的胶原蛋白支架,表现出更大的孔径和更高的孔隙率百分比、更规则的结构、更高的压缩模量、更大的吸水能力,并允许更多的 MSC 增殖和分化。这种包含海洋生物材料壳聚糖的多功能支架作为促进骨科组织修复的合适平台显示出巨大潜力,而使用鲑鱼皮来源的胶原蛋白可能更适合于皮肤等软组织的修复。
胶原蛋白因其生物相容性常用于组织工程;然而,它具有低机械强度和不可预测的降解速率。此外,与哺乳动物来源的胶原蛋白相关的高成本和朊病毒传播风险促使人们研究替代胶原蛋白来源,即海洋来源的胶原蛋白。在本研究中,将由鲑鱼皮胶原蛋白制成的支架与更常用的牛来源胶原蛋白进行了比较,重点是骨科应用。为了改善这些支架的机械性能,添加了另一种海洋生物材料壳聚糖以生产具有更高机械稳定性的支架。胶原蛋白 - 壳聚糖复合材料也被证明支持间充质干细胞向骨和软骨组织的分化。因此,这种多功能支架在骨和软骨再生应用中具有潜力。